Terry-Ann Burrell
Director of Finance/CFO at BEAM THERAPEUTICS INC.
Net worth: 2 M $ as of 30/04/2024
Terry-Ann Burrell active positions
Companies | Position | Start | End |
---|---|---|---|
BEAM THERAPEUTICS INC. | Director of Finance/CFO | 01/08/2019 | - |
Treasurer | 01/09/2019 | - | |
RECURSION PHARMACEUTICALS, INC. | Director/Board Member | 01/04/2020 | - |
Independent Dir/Board Member | 01/04/2020 | - | |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Director/Board Member | 16/01/2024 | - |
Career history of Terry-Ann Burrell
Former positions of Terry-Ann Burrell
Companies | Position | Start | End |
---|---|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01/05/2008 | 01/08/2019 |
Training of Terry-Ann Burrell
Harvard University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistics
International
United States | 7 |
Operational
Director/Board Member | 2 |
Director of Finance/CFO | 1 |
Treasurer | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
BEAM THERAPEUTICS INC. | Health Technology |
RECURSION PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Terry-Ann Burrell
- Experience